Market segmentation was validated, clinical pipeline timelines were confirmed, and insights regarding formulary adoption patterns, pricing strategies, and reimbursement dynamics were obtained through primary research
Can be worn day or night, even with high activity
Retatrutide should only be used within the context of a regulated clinical trial or, once licensed, through authorised supply channels
**Complementary Actives**: Vitamin C, niacinamide, or arbutin included
She has extensive experience managing, teaching, designing, conducting and analyzing HF research for products in the healthcare domain
We started with GLP-1s like WEGOVY, have progressed to GLP-1 + GIPR targeting agents like ZEPBOUND, and are nearing entry of GLP-1 + GIPR + Glucagon (Lillys retatrutide)